Genmab | GEN - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Agios Pharmaceuticals USD 128.55M 28.9M 2026-09
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 156.51M 12.95M 2026-09
Amgen USD 13.19B 799M 2026-09
argenx SE USD 2.6B 984M 2026-09
AstraZeneca USD 4.89B 2.67B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Demant DKK 1.5B 166M 2026-06
Exelixis USD 304.77M 23.33M 2026-09
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Genmab DKK 1.5B 18M 2026-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
GN Store Nord DKK 806M 59M 2026-06
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Insmed USD 396.56M 148.2M 2026-09
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 8.87B 1.25B 2026-09
Regeneron Pharmaceuticals USD 3.66B 1.2B 2026-09
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
UCB EUR 1.57B 1.14B 2024-12